Blood platelets contain tumor-derived RNA biomarkers

R. Jonas A Nilsson, Leonora Balaj, Esther Hulleman, Sjoerd Van Rijn, D. Michiel Pegtel, Maudy Walraven, Anders Widmark, Winald R. Gerritsen, Henk M. Verheul, W. Peter Vandertop, David P. Noske, Johan Skog, Thomas Würdinger

Research output: Contribution to journalArticle

Abstract

Diagnostic platforms providing biomarkers that are highly predictive for diagnosing, monitoring, and stratifying cancer patients are key instruments in the development of personalized medicine. We demonstrate that tumor cells transfer (mutant) RNA into blood platelets in vitro and in vivo, and show that blood platelets isolated from glioma and prostate cancer patients contain the cancer-associated RNA biomarkers EGFRvIII and PCA3, respectively. In addition, gene-expression profiling revealed a distinct RNA signature in platelets from glioma patients compared with normal control subjects. Because platelets are easily accessible and isolated, they may form an attractive platform for the companion diagnostics of cancer.

Original languageEnglish (US)
Pages (from-to)3680-3683
Number of pages4
JournalBlood
Volume118
Issue number13
DOIs
StatePublished - Sep 29 2011
Externally publishedYes

Fingerprint

Biomarkers
Platelets
Tumors
Blood
Blood Platelets
RNA
Glioma
Neoplasms
Precision Medicine
Gene Expression Profiling
Transfer RNA
Gene expression
Medicine
Prostatic Neoplasms
Cells
Monitoring

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Nilsson, R. J. A., Balaj, L., Hulleman, E., Van Rijn, S., Pegtel, D. M., Walraven, M., ... Würdinger, T. (2011). Blood platelets contain tumor-derived RNA biomarkers. Blood, 118(13), 3680-3683. https://doi.org/10.1182/blood-2011-03-344408

Blood platelets contain tumor-derived RNA biomarkers. / Nilsson, R. Jonas A; Balaj, Leonora; Hulleman, Esther; Van Rijn, Sjoerd; Pegtel, D. Michiel; Walraven, Maudy; Widmark, Anders; Gerritsen, Winald R.; Verheul, Henk M.; Vandertop, W. Peter; Noske, David P.; Skog, Johan; Würdinger, Thomas.

In: Blood, Vol. 118, No. 13, 29.09.2011, p. 3680-3683.

Research output: Contribution to journalArticle

Nilsson, RJA, Balaj, L, Hulleman, E, Van Rijn, S, Pegtel, DM, Walraven, M, Widmark, A, Gerritsen, WR, Verheul, HM, Vandertop, WP, Noske, DP, Skog, J & Würdinger, T 2011, 'Blood platelets contain tumor-derived RNA biomarkers', Blood, vol. 118, no. 13, pp. 3680-3683. https://doi.org/10.1182/blood-2011-03-344408
Nilsson RJA, Balaj L, Hulleman E, Van Rijn S, Pegtel DM, Walraven M et al. Blood platelets contain tumor-derived RNA biomarkers. Blood. 2011 Sep 29;118(13):3680-3683. https://doi.org/10.1182/blood-2011-03-344408
Nilsson, R. Jonas A ; Balaj, Leonora ; Hulleman, Esther ; Van Rijn, Sjoerd ; Pegtel, D. Michiel ; Walraven, Maudy ; Widmark, Anders ; Gerritsen, Winald R. ; Verheul, Henk M. ; Vandertop, W. Peter ; Noske, David P. ; Skog, Johan ; Würdinger, Thomas. / Blood platelets contain tumor-derived RNA biomarkers. In: Blood. 2011 ; Vol. 118, No. 13. pp. 3680-3683.
@article{5869c9db7403430d9074f5b68dfa0d9f,
title = "Blood platelets contain tumor-derived RNA biomarkers",
abstract = "Diagnostic platforms providing biomarkers that are highly predictive for diagnosing, monitoring, and stratifying cancer patients are key instruments in the development of personalized medicine. We demonstrate that tumor cells transfer (mutant) RNA into blood platelets in vitro and in vivo, and show that blood platelets isolated from glioma and prostate cancer patients contain the cancer-associated RNA biomarkers EGFRvIII and PCA3, respectively. In addition, gene-expression profiling revealed a distinct RNA signature in platelets from glioma patients compared with normal control subjects. Because platelets are easily accessible and isolated, they may form an attractive platform for the companion diagnostics of cancer.",
author = "Nilsson, {R. Jonas A} and Leonora Balaj and Esther Hulleman and {Van Rijn}, Sjoerd and Pegtel, {D. Michiel} and Maudy Walraven and Anders Widmark and Gerritsen, {Winald R.} and Verheul, {Henk M.} and Vandertop, {W. Peter} and Noske, {David P.} and Johan Skog and Thomas W{\"u}rdinger",
year = "2011",
month = "9",
day = "29",
doi = "10.1182/blood-2011-03-344408",
language = "English (US)",
volume = "118",
pages = "3680--3683",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "13",

}

TY - JOUR

T1 - Blood platelets contain tumor-derived RNA biomarkers

AU - Nilsson, R. Jonas A

AU - Balaj, Leonora

AU - Hulleman, Esther

AU - Van Rijn, Sjoerd

AU - Pegtel, D. Michiel

AU - Walraven, Maudy

AU - Widmark, Anders

AU - Gerritsen, Winald R.

AU - Verheul, Henk M.

AU - Vandertop, W. Peter

AU - Noske, David P.

AU - Skog, Johan

AU - Würdinger, Thomas

PY - 2011/9/29

Y1 - 2011/9/29

N2 - Diagnostic platforms providing biomarkers that are highly predictive for diagnosing, monitoring, and stratifying cancer patients are key instruments in the development of personalized medicine. We demonstrate that tumor cells transfer (mutant) RNA into blood platelets in vitro and in vivo, and show that blood platelets isolated from glioma and prostate cancer patients contain the cancer-associated RNA biomarkers EGFRvIII and PCA3, respectively. In addition, gene-expression profiling revealed a distinct RNA signature in platelets from glioma patients compared with normal control subjects. Because platelets are easily accessible and isolated, they may form an attractive platform for the companion diagnostics of cancer.

AB - Diagnostic platforms providing biomarkers that are highly predictive for diagnosing, monitoring, and stratifying cancer patients are key instruments in the development of personalized medicine. We demonstrate that tumor cells transfer (mutant) RNA into blood platelets in vitro and in vivo, and show that blood platelets isolated from glioma and prostate cancer patients contain the cancer-associated RNA biomarkers EGFRvIII and PCA3, respectively. In addition, gene-expression profiling revealed a distinct RNA signature in platelets from glioma patients compared with normal control subjects. Because platelets are easily accessible and isolated, they may form an attractive platform for the companion diagnostics of cancer.

UR - http://www.scopus.com/inward/record.url?scp=80053356340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053356340&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-03-344408

DO - 10.1182/blood-2011-03-344408

M3 - Article

C2 - 21832279

AN - SCOPUS:80053356340

VL - 118

SP - 3680

EP - 3683

JO - Blood

JF - Blood

SN - 0006-4971

IS - 13

ER -